Alcázar-Navarrete, B., Figueira-Gonçalves, J. M., Blanco Cid, N., Bruguera Avila, N., Bernabeu Mora, R., Fuster Gomila, A., . . . Sánchez-Covisa, J. (2026). Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study.
Chicago Style CitationAlcázar-Navarrete, Bernardino, et al. Real-World Outcomes Across Baseline Risk Profiles in Patients With COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights From the ORESTES Study. 2026.
MLA CitationAlcázar-Navarrete, Bernardino, et al. Real-World Outcomes Across Baseline Risk Profiles in Patients With COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights From the ORESTES Study. 2026.